Tech

The Download: GLP-1s and eating disorders, self-aware cities, and forever chemicals

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 30/10/2026, 12:20:24 UTC.

Briefings

A biotech newsletter reports a 71% global rise in anorexia and bulimia between 1990 and 2023, with GLP-1 weight-loss drugs potentially exacerbating the condition. The newsletter also covers PFAS 'forever chemicals' linked to health risks, a recent crypto hack affecting $6.3 billion at Binance, and a fictional short story about self-aware cities. The article notes that AI is gaining traction in animal welfare advocacy and that the Bay Area's animal welfare movement is receiving funding from AI lab employees.

Key points

• A new report indicates the global incidence of anorexia nervosa and bulimia nervosa increased by 71% between 1990 and 2023.
• GLP-1 weight-loss drugs are being associated with exacerbating eating disorders, potentially worsening an already growing problem.

Context

This briefing covers findings from The Download, a weekday technology newsletter, alongside related topics from The Checkup. It includes data on biotech breakthroughs, health trends, and recent tech incidents.

Limitations

The evidence is limited to the provided newsletter content; specific clinical data sources are not cited. The 71% increase figure is from a report, and the link between GLP-1s and eating disorders is a clinical observation, not a confirmed causal study. The fictional story and AI funding for animal welfare are speculative or reported as trends, not verified facts.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 30/10/2026, 12:41:41 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiel6bffnofffjlmk2rgo6lixj7u6ofnowme5wrenbefybpdhudrxu